CGCABLE
834639
KLT
831689
DAYU BIOLOGICAL
871970
4
Fujian Superpipe
300198
5
WuHan Hvsen Biotechnology
300871
CN Stock MarketDetailed Quotes
300323 BOE HC SemiTek Corporation
- 7.25
- +0.03+0.42%
Market Closed Mar 26 15:00 CST
11.77BMarket Cap-19.23P/E (TTM)
7.34High7.19Low166.71KlotVolume7.19Open7.22Pre Close121.07MTurnover1.90%Turnover RatioLossP/E (Static)1.62BShares10.9352wk High1.70P/B6.37BFloat Cap3.7952wk Low8.66Limit Up879.15MShs Float23.71Historical High5.78Limit Down2.08%Amplitude2.27Historical Low--Dividend TTM7.26Avg Price81.86KlotAsk--Div YieldTTM100Lot Size82.12KlotBid
BOE HC SemiTek Corporation Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -42.20%941.58M | -52.73%938.49M | 7.41%1.08B | 43.94%1.31B | 38.00%1.63B | 66.94%1.99B | -29.21%1B | -33.42%906.68M | 27.03%1.18B | 44.11%1.19B |
| Transactional financial assets | -71.39%119.97M | -54.11%219.11M | 492.55%418.84M | 490.55%419.06M | 490.87%419.28M | 179.75%477.49M | 241.72%70.69M | 243.01%70.96M | -67.85%70.96M | -36.94%170.69M |
| Notes receivable and accounts receivable | 10.30%1.29B | 25.89%1.28B | 34.74%1.26B | 44.10%1.19B | 45.49%1.17B | 6.93%1.02B | -18.21%935.74M | -30.29%824.42M | -29.12%804.58M | -20.35%954.37M |
| -Notes receivable | -9.81%282.49M | 44.41%328.87M | 49.16%343.72M | 40.48%320.49M | 22.50%313.22M | -29.33%227.73M | -45.00%230.43M | -41.73%228.14M | -40.86%255.68M | -18.67%322.25M |
| -Accounts receivable | 17.64%1.01B | 20.56%955.82M | 30.02%917.05M | 45.49%867.54M | 56.20%857.37M | 25.42%792.79M | -2.74%705.31M | -24.63%596.28M | -21.90%548.89M | -21.18%632.11M |
| Other receivables (including interest and dividends) | 1,044.25%56.83M | 63.29%5.73M | -81.39%4.62M | -96.33%5.79M | -96.89%4.97M | -97.73%3.51M | -80.31%24.83M | 263.70%158.03M | -9.74%159.51M | 43.79%154.82M |
| -Other receivable | 1,044.25%56.83M | ---- | -81.39%4.62M | ---- | -96.89%4.97M | ---- | -80.31%24.83M | ---- | -9.74%159.51M | ---- |
| Advance payment | 103.49%68.34M | -36.45%31.47M | 18.25%49.69M | 90.94%63.23M | 0.92%33.58M | 77.95%49.52M | 91.09%42.02M | 23.80%33.12M | -32.77%33.28M | -11.94%27.83M |
| Inventories | 0.95%1.11B | 1.47%1.21B | -11.97%1.11B | -18.78%1.14B | -20.63%1.1B | -17.86%1.19B | -8.81%1.27B | 3.52%1.41B | 5.80%1.39B | 28.98%1.45B |
| Receivable financing | -44.50%71.84M | -64.88%99.79M | -32.20%113.65M | -33.15%190.75M | -58.20%129.44M | -9.13%284.18M | -28.49%167.63M | -3.51%285.33M | -13.57%309.63M | -16.38%312.72M |
| Other current assets | 645.50%142.93M | 450.97%117.64M | 128.80%66.26M | 106.30%38.86M | -44.72%19.17M | 22.10%21.35M | 122.23%28.96M | -95.27%18.84M | -91.54%34.68M | -94.58%17.49M |
| Total current assets | -15.60%3.8B | -22.39%3.91B | 16.02%4.1B | 17.53%4.35B | 13.25%4.51B | 17.65%5.04B | -18.93%3.54B | -20.98%3.7B | -13.41%3.98B | 0.43%4.28B |
| Non Current assets | ||||||||||
| Other equity investment | 1.49%3.32M | -2.40%3.23M | -1.37%3.29M | 3.25%3.27M | 1.70%3.27M | 1.13%3.31M | 7.66%3.33M | 8.25%3.17M | 9.24%3.21M | 9.47%3.28M |
| Investment real estate | -10.06%62.79M | -9.81%64.55M | 1.09%66.31M | 1.34%68.06M | 1.58%69.82M | 1.81%71.57M | -8.74%65.59M | -8.55%67.16M | -8.37%68.73M | 37.86%70.3M |
| Long-term equity investment | 232,920.22%20.95M | 32,907.09%3.01M | -99.97%9.05K | -99.97%9.01K | -99.97%8.99K | -99.97%9.12K | 0.85%30.26M | 373,447.78%30.11M | 371,838.29%30.11M | 8,589.38%30.01M |
| Long term receivable account | 55.44%492.07K | -90.23%488.24K | -90.14%484.46K | -90.06%480.72K | -93.35%316.56K | 7.07%5M | 7.01%4.92M | 14.27%4.84M | 14.33%4.76M | 13.96%4.67M |
| Fixed assets | 3.43%5.07B | ---- | -7.33%4.64B | ---- | 9.19%4.9B | ---- | 27.59%5.01B | ---- | 8.84%4.49B | ---- |
| Constru in process | 400.45%2.01B | ---- | 83.24%765.88M | ---- | -64.76%400.82M | ---- | -74.46%417.96M | ---- | -26.21%1.14B | ---- |
| Intangible assets | 7.75%890.35M | 0.32%870.42M | 15.03%892.15M | 10.63%837.73M | 7.17%826.35M | 15.76%867.64M | 10.20%775.54M | 11.25%757.21M | 17.12%771.07M | 13.98%749.5M |
| Development expenditure | -34.53%109.32M | -15.94%116.82M | -24.07%101.48M | 37.98%157.41M | 87.61%166.98M | 49.56%138.98M | 7.87%133.65M | -14.23%114.08M | -36.35%89M | -21.19%92.93M |
| Long deferred expense | -32.24%14.38M | -30.13%14.35M | 20.74%16.83M | 13.87%19.68M | 6.09%21.22M | -10.01%20.54M | 1.35%13.94M | 11.76%17.28M | 16.92%20M | 21.33%22.82M |
| Deferred tax assets | 40.07%510.12M | -2.07%455.7M | -0.83%421.2M | 1.44%390.69M | 0.47%364.2M | 55.30%465.32M | 47.42%424.74M | 33.11%385.16M | 24.84%362.51M | -5.57%299.63M |
| Usufruct assets | 657.87%19.82M | 575.37%20.8M | 512.78%21.77M | 710.69%22.75M | -19.27%2.62M | -27.71%3.08M | -11.63%3.55M | 731.02%2.81M | 690.21%3.24M | -96.96%4.26M |
| Other non current assets | 36.09%146.56M | 888.55%723.92M | 601.73%578.71M | 192.66%284.48M | -11.22%107.69M | -27.21%73.23M | -33.88%82.47M | -7.01%97.2M | -48.45%121.3M | -64.55%100.61M |
| Total non current assets | 28.97%8.86B | 16.81%8.15B | 7.82%7.51B | 0.10%7.01B | -3.32%6.87B | 0.89%6.97B | 0.51%6.97B | 1.08%7B | 0.16%7.1B | 4.90%6.91B |
| Total assets | 11.31%12.66B | 0.37%12.05B | 10.58%11.62B | 6.13%11.36B | 2.63%11.37B | 7.30%12.01B | -7.00%10.5B | -7.83%10.71B | -5.18%11.08B | 3.14%11.19B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 43.82%1.27B | 35.74%1.31B | 4.91%1.29B | -24.92%1.13B | -40.50%883.83M | -38.09%963.37M | -9.41%1.23B | 15.20%1.51B | 1.28%1.49B | 21.55%1.56B |
| Notes payable and accounts payable | 67.86%1.75B | 17.08%1.18B | 17.83%1.05B | 4.28%818.88M | 5.71%1.04B | -2.15%1.01B | -18.51%890.76M | -33.73%785.28M | -33.99%986.11M | -3.63%1.03B |
| -Notes payable | 61.46%449.95M | -44.88%189.06M | 6.58%317.61M | -5.06%237.88M | -28.99%278.67M | -19.31%343M | -37.84%298.01M | -52.92%250.57M | -38.14%392.46M | -8.59%425.08M |
| -Accounts payable | 70.19%1.3B | 49.01%991.8M | 23.49%731.99M | 8.66%581M | 28.65%763.72M | 9.90%665.6M | -3.41%592.76M | -18.09%534.71M | -30.92%593.65M | 0.18%605.66M |
| Contract liabilities | 945.88%11.4M | -56.72%1.92M | 140.49%4.56M | 46.98%1.52M | 6.15%1.09M | 438.82%4.45M | 199.40%1.9M | -91.79%1.04M | -3.84%1.03M | -63.13%825.29K |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | --2.24M | ---- | ---- | ---- | ---- |
| Salaries payable | 27.37%106.5M | 25.54%80.38M | -8.22%49.27M | 15.64%49.3M | 25.95%83.61M | 7.29%64.02M | -9.30%53.68M | -22.52%42.64M | -10.51%66.38M | 46.42%59.67M |
| Taxs payable | 16.97%21.82M | -3.39%21.24M | 98.10%31.08M | 36.47%19.09M | -3.83%18.65M | 123.53%21.98M | 70.85%15.69M | 2.47%13.99M | 53.68%19.39M | 1.62%9.83M |
| Other payable (including interest and dividends) | 23.65%90.7M | 2.29%53.03M | 45.55%69.19M | 52.55%64.39M | 63.77%73.35M | 34.34%51.85M | 20.83%47.54M | -14.91%42.21M | 9.32%44.79M | -12.29%38.59M |
| -Other payable | 23.65%90.7M | ---- | 45.55%69.19M | ---- | 63.77%73.35M | ---- | 20.83%47.54M | ---- | 9.32%44.79M | ---- |
| Non current liabilities due within one year | -14.26%411.31M | -48.08%353.75M | -47.65%373.43M | -32.58%488.52M | -23.87%479.73M | 20.99%681.39M | 31.05%713.28M | 50.40%724.59M | 39.79%630.13M | 17.63%563.18M |
| Other current liabilities | 33.24%185.16M | 256.79%222.53M | 171.32%221.15M | 66.76%155.31M | 45.73%138.97M | -44.30%62.37M | -25.41%81.51M | -27.22%93.13M | -51.21%95.36M | -31.24%111.98M |
| Total current liabilities | 41.38%3.85B | 12.62%3.22B | 1.79%3.09B | -15.00%2.73B | -18.24%2.72B | -15.15%2.86B | -5.55%3.03B | -0.73%3.21B | -10.89%3.33B | 9.16%3.37B |
| Current liabilities | ||||||||||
| Long term loan | 87.21%1.71B | 57.21%1.49B | -4.13%1.06B | 17.43%1B | -6.92%911.67M | -0.57%948.8M | -1.40%1.1B | -38.56%852.66M | 4.13%979.48M | 22.65%954.25M |
| Long term account payable | ---- | ---- | ---- | ---- | ---- | ---- | -80.15%8.29M | ---- | -57.27%24.76M | ---- |
| Estimate liabilities | -53.84%1.65M | 0.00%3.58M | 0.00%3.58M | 0.00%3.58M | -3.78%3.58M | --3.58M | --3.58M | --3.58M | --3.72M | ---- |
| Deferred tax liabilities | ---- | ---- | ---- | ---- | ---- | 0.47%167.97M | -0.12%172.47M | -0.14%178.02M | -0.41%183.75M | -20.32%167.18M |
| Long term deferred income | -26.08%149.89M | -33.22%145.5M | -31.07%162.48M | -28.68%182.55M | -26.57%202.77M | -21.02%217.89M | -20.60%235.72M | -19.76%255.95M | -18.49%276.13M | -23.80%275.88M |
| Lease liabilities | 2,023.61%18.99M | 1,280.71%19.43M | 937.71%19.87M | 1,343.47%21.47M | -51.61%894.37K | -53.18%1.41M | -28.73%1.91M | --1.49M | 1,323.38%1.85M | -95.46%3.01M |
| Total non current liabilities | 67.78%1.88B | 23.92%1.66B | -18.47%1.24B | -7.60%1.21B | -23.87%1.12B | -6.53%1.34B | -6.60%1.52B | -32.39%1.31B | -3.43%1.47B | 1.22%1.43B |
| Total liabilities | 49.07%5.73B | 16.23%4.88B | -4.99%4.33B | -12.86%3.94B | -19.96%3.84B | -12.58%4.2B | -5.91%4.56B | -12.58%4.52B | -8.73%4.8B | 6.66%4.8B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.39%1.62B | 0.00%1.62B | 29.89%1.62B | 29.89%1.62B | 30.35%1.62B | 30.35%1.62B | 0.35%1.24B | 0.35%1.24B | 0.00%1.24B | 0.00%1.24B |
| Capital reserve funds | 0.33%6.88B | 0.00%6.85B | 32.85%6.85B | 32.85%6.85B | 33.47%6.85B | 33.47%6.85B | 0.25%5.16B | 0.27%5.16B | 0.00%5.14B | 0.20%5.14B |
| Surplus reserve funds | 0.00%82.58M | 0.00%82.58M | 0.00%82.58M | 0.00%82.58M | 0.00%82.58M | 0.00%82.58M | 0.00%82.58M | 0.00%82.58M | 0.00%82.58M | 0.00%82.58M |
| Retained profit | -59.63%-1.64B | -85.18%-1.38B | -134.11%-1.27B | -273.62%-1.13B | -471.94%-1.02B | -919.71%-747.61M | -2,520.23%-543.04M | -1,110.73%-303.07M | -457.17%-179.19M | 29.10%-73.32M |
| Less:Treasury stock | --16.95M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income | 6.06%2.52M | -7.24%2.33M | -5.45%2.43M | 5.38%2.4M | -0.65%2.38M | -2.21%2.51M | 28.60%2.57M | 67.46%2.28M | 68.76%2.39M | 53.70%2.56M |
| Specific reserves | --493.59K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders equity without minority interests | -7.95%6.93B | -8.16%7.17B | 22.51%7.28B | 20.01%7.42B | 19.89%7.53B | 22.25%7.81B | -7.82%5.95B | -4.01%6.19B | -2.27%6.28B | 0.65%6.39B |
| Total shareholder equity | -7.95%6.93B | -8.16%7.17B | 22.51%7.28B | 20.01%7.42B | 19.89%7.53B | 22.25%7.81B | -7.82%5.95B | -4.01%6.19B | -2.27%6.28B | 0.65%6.39B |
| Total liabilityies and equity | 11.31%12.66B | 0.37%12.05B | 10.58%11.62B | 6.13%11.36B | 2.63%11.37B | 7.30%12.01B | -7.00%10.5B | -7.83%10.71B | -5.18%11.08B | 3.14%11.19B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.